BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 17511942)

  • 21. Hansen's disease mimicking palmoplantar keratoderma.
    Agrawal US; Saxena A; Meena RS; Saini M; Saxena V
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):210-2. PubMed ID: 12483971
    [No Abstract]   [Full Text] [Related]  

  • 22. Histoid leprosy; report of three cases.
    Krishna KK
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):174-6. PubMed ID: 10472376
    [No Abstract]   [Full Text] [Related]  

  • 23. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
    Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molluscum contagiosum-like lesions in lepromatous leprosy.
    Mukhopadhyay AK
    Indian J Lepr; 2005; 77(2):156-61. PubMed ID: 16044815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythema nodosum leprosum associated with minocycline.
    Travassos AR; Antunes J; Pacheco D; Almeida LS; Filipe P; Marques MS
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):39-41. PubMed ID: 23000940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Leprosy. Pathogenesis--classification--diagnosis--treatment].
    Stingl P
    Hautarzt; 1990 Mar; 41(3):126-30. PubMed ID: 2188935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sub-polar lepromatous leprosy localized to the face.
    George M; Rajan U; George S; Pakran J; Thomas S
    Dermatol Online J; 2010 Sep; 16(9):8. PubMed ID: 20875329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autochthonous leprosy in metropolitan France presenting with a diffuse infiltration of the face and febrile illness.
    Ezzedine K; Malvy D; Beylot C; Longy-Boursier M
    Int J Dermatol; 2009 Jan; 48(1):69-72. PubMed ID: 19126055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leprosy: recognizing red flags.
    Pearce V; Horton JJ
    Australas J Dermatol; 2008 Nov; 49(4):226-8. PubMed ID: 18855787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wade's histoid leprosy: three clinical presentations.
    Pereyra SB; Danielo CA; Ponssa GJ; Consigli JE; Papa MB; Ghirardi G
    Int J Dermatol; 2007 Sep; 46(9):944-6. PubMed ID: 17822497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
    Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
    Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latapi's lepromatosis (Lucio's leprosy) without Lucio's phenomenon in a pubertal boy.
    Rea TH
    Lepr Rev; 2009 Dec; 80(4):445-7. PubMed ID: 20306644
    [No Abstract]   [Full Text] [Related]  

  • 34. Lepromatous leprosy of histoid type.
    Annigeri SR; Metgud SC; Patil JR
    Indian J Med Microbiol; 2007 Jan; 25(1):70-1. PubMed ID: 17377360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant cells lepromatous leprosy. Diffuse dermatitis with exuberant foreign body giant cells in treated lepromatous leprosy.
    Rodríguez G; Arias V
    Biomedica; 2019 Aug; 39(Supl. 2):26-31. PubMed ID: 31529831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persister studies in leprosy patients after multi-drug treatment.
    Gupta UD; Katoch K; Singh HB; Natrajan M; Katoch VM
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):100-4. PubMed ID: 16830652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annular lesions in a 70-year-old Austrian man.
    Reiter H; Justich A; Massone C
    Am J Dermatopathol; 2011 Dec; 33(8):861-2, 869-70. PubMed ID: 22024575
    [No Abstract]   [Full Text] [Related]  

  • 39. Joint chemotherapy trials in lepromatous leprosy conducted in Thailand, the Philippines, and Korea.
    Cellona RV; Fajardo TT; Kim DI; Hah YM; Ramasoota T; Sampattavanich S; Carrillo MP; Abalos RM; dela Cruz EC; Ito T
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):1-11. PubMed ID: 2181040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.